A chilling trend has emerged from a comprehensive 40-year study spanning 1984 to 2023, analyzing nearly half a million prostate cancer cases and 150,000 deaths. The research, a collaboration between the University of Ottawa and Statistics Canada, reveals a disturbing rise in advanced-stage diagnoses.
